Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
AKT inhib
Welcome,
Profile
Billing
Logout
56 Companies
40 Products
40 Products
483 Diseases
339 Trials
12681 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
26
52
78
104
130
156
182
208
234
260
Epidaza
(chidamide) / Chipscreen, Meiji Seika, Eisai, HUYA Bioscience
Viracept
(nelfinavir) / ViiV Healthcare, Roche
ipatasertib
(RG7440) / Roche
Truqap
(capivasertib) / Otsuka, AstraZeneca
Kinenza
(enzastaurin) / Denovo, Aytu BioPharma
MK-2206
/ Merck (MSD)
perifosine
(D21266) / AEterna Zentaris
dordaviprone
(ONC201) / Chimerix
Estybon
(rigosertib) / Onconova, SymBio Pharma, Knight Therap
Turalio
(pexidartinib) / Daiichi Sankyo
7-Hydroxystaurosporine
(UCN-01) / National Cancer Institute
afuresertib
(LAE002) / Laekna Therap
paxalisib
(GDC-0084) / Kazia, SoVarGen
uprosertib
(LAE003) / Laekna Therap
Hocena
(antroquinonol) / Golden Biotechnology
phenoxodiol
(NV06) / MEI
sonolisib
(PX 866) / Pfizer
ABTL0812
/ Ability Pharma
triciribine phosphate
(PTX-200) / VioQuest, Prescient Therap
LY2780301
/ Eli Lilly
SM-020
/ DermBiont
CD8+NKG2D+ AKT cell immunotherapy
/ iCELL Biotechnology
DFN-529
/ CervoMed
GSK690693
/ GSK
NTQ1062
/ Sino Biopharm
PCUR-101
/ Pellficure
luxeptinib
(CG-806) / Aptose Biosci
oleandrin
(PBI-05204) / Phoenix Biotech
pifusertib
(TAS-117) / Otsuka
quinacrine
(CBL0102) / Incuron
AT13148
/ Otsuka
BAY 1125976
/ Bayer
HRS7415
/ Jiangsu Hengrui Pharma
LY294002
/ Eli Lilly
ME-143
/ MEI
OB318
/ Microbio
SR13668
/ SRI International
TAS0612
/ Otsuka
VAD044
/ Vaderis
XL418
/ Exelixis
misetionamide
(GP-2250) / Panavance Therap
rupitasertib
(DIACC3010) / Evexta Bio
